business
Biotech Buys Autoimmune Firm for $7B
Biotech Buys Autoimmune Firm for $7B
Kerry Grens | Jul 16, 2015
Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.
Celladon Shutters Its R&D
Celladon Shutters Its R&D
Kerry Grens | Jun 26, 2015
Biotech firm likely to pull the plug after its gene therapy product fails.
Another CAR-T IPO
Another CAR-T IPO
Jef Akst | Apr 6, 2015
Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.
Roche Snags Tumor Tester for $1B
Roche Snags Tumor Tester for $1B
Kerry Grens | Jan 13, 2015
The pharmaceutical company bought a majority stake in Foundation Medicine, a firm that develops personalized cancer-medicine diagnostics.
SAIC Founder Dies
SAIC Founder Dies
Kerry Grens | Dec 30, 2014
J. Robert Beyster, who established one of the largest research and engineering firms, passed away at age 90.
Merck Buys Sigma-Aldrich for $17B
Merck Buys Sigma-Aldrich for $17B
Kerry Grens | Sep 22, 2014
Two giants merge as the German drug maker acquires the US-based science supply company.
Keeping Up with IP
Keeping Up with IP
Kate Yandell | Sep 1, 2014
It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.
Roche Buys Biotech for $8.3B
Roche Buys Biotech for $8.3B
Jef Akst | Aug 27, 2014
The pharma giant strikes a deal to acquire InterMune, a Brisbane, California-based biotech with only one product—a treatment for a fatal lung disease.
Biotech Terminates IPO
Biotech Terminates IPO
Jyoti Madhusoodanan | Aug 15, 2014
The Israeli firm Vascular Biogenics withdrew its initial public offering after six days of trading. 
Scripps’s President Steps Down
Scripps’s President Steps Down
Kerry Grens | Jul 23, 2014
Following widespread disapproval among faculty members, Scripps’s Michael Marletta resigns his post.